BindingDB logo
myBDB logout

Patent code US9682940

Compile Data Set for Download or QSAR

Found 502 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)		LigandTarget/Host
Links		Ligand
Links		Trg + Lig
Links		Ki
nM		ΔG°
kJ/mole		IC50
nM		Kd
nM		EC50/IC50
nM		koff
s-1		kon
M-1s-1		pHTemp
°C
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM111136
PNG
(US9682940, 27)
Show SMILES OC(=O)c1ccc(cc1)S(=O)(=O)N1CCC(CC1)c1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C32H27Cl2N3O4S/c33-25-8-1-20(2-9-25)30(21-3-10-26(34)11-4-21)24-7-14-29-28(19-24)31(36-35-29)22-15-17-37(18-16-22)42(40,41)27-12-5-23(6-13-27)32(38)39/h1-14,19,22,30H,15-18H2,(H,35,36)(H,38,39)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 410n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM111138
PNG
(US9682940, 28)
Show SMILES NC(=O)c1ccc(cc1)S(=O)(=O)N1CCC(CC1)c1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C32H28Cl2N4O3S/c33-25-8-1-20(2-9-25)30(21-3-10-26(34)11-4-21)24-7-14-29-28(19-24)31(37-36-29)22-15-17-38(18-16-22)42(40,41)27-12-5-23(6-13-27)32(35)39/h1-14,19,22,30H,15-18H2,(H2,35,39)(H,36,37)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM111142
PNG
(US9682940, 32)
Show SMILES FC(F)(F)c1ccc(cc1)S(=O)(=O)N1CCC(CC1)c1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C32H26Cl2F3N3O2S/c33-25-8-1-20(2-9-25)30(21-3-10-26(34)11-4-21)23-5-14-29-28(19-23)31(39-38-29)22-15-17-40(18-16-22)43(41,42)27-12-6-24(7-13-27)32(35,36)37/h1-14,19,22,30H,15-18H2,(H,38,39)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 71n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM111143
PNG
(US9682940, 33)
Show SMILES FC(F)(F)c1ccccc1S(=O)(=O)N1CCC(CC1)c1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C32H26Cl2F3N3O2S/c33-24-10-5-20(6-11-24)30(21-7-12-25(34)13-8-21)23-9-14-28-26(19-23)31(39-38-28)22-15-17-40(18-16-22)43(41,42)29-4-2-1-3-27(29)32(35,36)37/h1-14,19,22,30H,15-18H2,(H,38,39)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM113303
PNG
(US9682940, 43)
Show SMILES NC(=O)CCC(=O)N1CCC(CC1)c1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C29H28Cl2N4O2/c30-22-6-1-18(2-7-22)28(19-3-8-23(31)9-4-19)21-5-10-25-24(17-21)29(34-33-25)20-13-15-35(16-14-20)27(37)12-11-26(32)36/h1-10,17,20,28H,11-16H2,(H2,32,36)(H,33,34)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 169n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM113309
PNG
(US9682940, 48)
Show SMILES FC(F)(F)S(=O)(=O)N1CCC(CC1)c1nn(-c2ccccc2Cl)c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C32H25Cl3F3N3O2S/c33-24-10-5-20(6-11-24)30(21-7-12-25(34)13-8-21)23-9-14-28-26(19-23)31(39-41(28)29-4-2-1-3-27(29)35)22-15-17-40(18-16-22)44(42,43)32(36,37)38/h1-14,19,22,30H,15-18H2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 31n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM113389
PNG
(US9682940, 56)
Show SMILES FC(F)(F)CC(=O)N1CCC(CC1)c1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C28H24Cl2F3N3O/c29-21-6-1-17(2-7-21)26(18-3-8-22(30)9-4-18)20-5-10-24-23(15-20)27(35-34-24)19-11-13-36(14-12-19)25(37)16-28(31,32)33/h1-10,15,19,26H,11-14,16H2,(H,34,35)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 72n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM113389
PNG
(US9682940, 56)
Show SMILES FC(F)(F)CC(=O)N1CCC(CC1)c1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C28H24Cl2F3N3O/c29-21-6-1-17(2-7-21)26(18-3-8-22(30)9-4-18)20-5-10-24-23(15-20)27(35-34-24)19-11-13-36(14-12-19)25(37)16-28(31,32)33/h1-10,15,19,26H,11-14,16H2,(H,34,35)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM113421
PNG
(US9682940, 57)
Show SMILES FC(F)(F)c1cccc(c1)-n1nc(C2CCN(CC2)S(=O)(=O)C(F)(F)F)c2cc(ccc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C33H25Cl2F6N3O2S/c34-25-9-4-20(5-10-25)30(21-6-11-26(35)12-7-21)23-8-13-29-28(18-23)31(22-14-16-43(17-15-22)47(45,46)33(39,40)41)42-44(29)27-3-1-2-24(19-27)32(36,37)38/h1-13,18-19,22,30H,14-17H2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM113560
PNG
(US9682940, 59)
Show SMILES FC(F)(F)c1cccc(c1)S(=O)(=O)N1CCC(CC1)c1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C32H26Cl2F3N3O2S/c33-25-9-4-20(5-10-25)30(21-6-11-26(34)12-7-21)23-8-13-29-28(18-23)31(39-38-29)22-14-16-40(17-15-22)43(41,42)27-3-1-2-24(19-27)32(35,36)37/h1-13,18-19,22,30H,14-17H2,(H,38,39)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 374n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM113575
PNG
(US9682940, 61)
Show SMILES OC(=O)c1cccc(c1)S(=O)(=O)N1CCC(CC1)c1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C32H27Cl2N3O4S/c33-25-9-4-20(5-10-25)30(21-6-11-26(34)12-7-21)23-8-13-29-28(19-23)31(36-35-29)22-14-16-37(17-15-22)42(40,41)27-3-1-2-24(18-27)32(38)39/h1-13,18-19,22,30H,14-17H2,(H,35,36)(H,38,39)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM113769
PNG
(US9682940, 63)
Show SMILES Cn1nc(C2CCN(CC2)S(=O)(=O)c2cccc(c2)C(O)=O)c2cc(ccc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C33H29Cl2N3O4S/c1-37-30-14-9-24(31(21-5-10-26(34)11-6-21)22-7-12-27(35)13-8-22)20-29(30)32(36-37)23-15-17-38(18-16-23)43(41,42)28-4-2-3-25(19-28)33(39)40/h2-14,19-20,23,31H,15-18H2,1H3,(H,39,40)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 66n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM115162
PNG
(US9682940, 69)
Show SMILES NC(=O)c1ccc(cc1)S(=O)(=O)N1CCC(CC1)c1nn(CCO)c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C34H32Cl2N4O4S/c35-27-8-1-22(2-9-27)32(23-3-10-28(36)11-4-23)26-7-14-31-30(21-26)33(38-40(31)19-20-41)24-15-17-39(18-16-24)45(43,44)29-12-5-25(6-13-29)34(37)42/h1-14,21,24,32,41H,15-20H2,(H2,37,42)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM115166
PNG
(US9682940, 72)
Show SMILES NS(=O)(=O)c1ccc(cc1)C(=O)N1CCC(CC1)c1nn(CCO)c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C34H32Cl2N4O4S/c35-27-8-1-22(2-9-27)32(23-3-10-28(36)11-4-23)26-7-14-31-30(21-26)33(38-40(31)19-20-41)24-15-17-39(18-16-24)34(42)25-5-12-29(13-6-25)45(37,43)44/h1-14,21,24,32,41H,15-20H2,(H2,37,43,44)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM115168
PNG
(US9682940, 73)
Show SMILES OC(=O)Cn1nc(C2CCN(CC2)S(=O)(=O)C(F)(F)F)c2cc(ccc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C28H24Cl2F3N3O4S/c29-21-6-1-17(2-7-21)26(18-3-8-22(30)9-4-18)20-5-10-24-23(15-20)27(34-36(24)16-25(37)38)19-11-13-35(14-12-19)41(39,40)28(31,32)33/h1-10,15,19,26H,11-14,16H2,(H,37,38)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 762n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM115170
PNG
(US9682940, 75)
Show SMILES CCOC(=O)Cn1nc(C2CCN(CC2)S(=O)(=O)C(F)(F)F)c2cc(ccc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C30H28Cl2F3N3O4S/c1-2-42-27(39)18-38-26-12-7-22(28(19-3-8-23(31)9-4-19)20-5-10-24(32)11-6-20)17-25(26)29(36-38)21-13-15-37(16-14-21)43(40,41)30(33,34)35/h3-12,17,21,28H,2,13-16,18H2,1H3
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM115171
PNG
(US9682940, 76)
Show SMILES CC(C)(C)OC(=O)N1CCC(CC1)c1nn(CCO)c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C32H35Cl2N3O3/c1-32(2,3)40-31(39)36-16-14-23(15-17-36)30-27-20-24(8-13-28(27)37(35-30)18-19-38)29(21-4-9-25(33)10-5-21)22-6-11-26(34)12-7-22/h4-13,20,23,29,38H,14-19H2,1-3H3
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM115373
PNG
(US9682940, 219 | US9682940, 81)
Show SMILES FC(F)S(=O)(=O)N1CCC(CC1)c1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C26H23Cl2F2N3O2S/c27-20-6-1-16(2-7-20)24(17-3-8-21(28)9-4-17)19-5-10-23-22(15-19)25(32-31-23)18-11-13-33(14-12-18)36(34,35)26(29)30/h1-10,15,18,24,26H,11-14H2,(H,31,32)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM115378
PNG
(US9682940, 88)
Show SMILES OC(=O)c1cccc(c1)S(=O)(=O)N1CCC(CC1)c1nn(C2CC2)c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C35H31Cl2N3O4S/c36-27-9-4-22(5-10-27)33(23-6-11-28(37)12-7-23)25-8-15-32-31(21-25)34(38-40(32)29-13-14-29)24-16-18-39(19-17-24)45(43,44)30-3-1-2-26(20-30)35(41)42/h1-12,15,20-21,24,29,33H,13-14,16-19H2,(H,41,42)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 115n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM115378
PNG
(US9682940, 88)
Show SMILES OC(=O)c1cccc(c1)S(=O)(=O)N1CCC(CC1)c1nn(C2CC2)c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C35H31Cl2N3O4S/c36-27-9-4-22(5-10-27)33(23-6-11-28(37)12-7-23)25-8-15-32-31(21-25)34(38-40(32)29-13-14-29)24-16-18-39(19-17-24)45(43,44)30-3-1-2-26(20-30)35(41)42/h1-12,15,20-21,24,29,33H,13-14,16-19H2,(H,41,42)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM115381
PNG
(US9682940, 91)
Show SMILES OCC(=O)N1CCC(CC1)c1nn(C2CC2)c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C30H29Cl2N3O2/c31-23-6-1-19(2-7-23)29(20-3-8-24(32)9-4-20)22-5-12-27-26(17-22)30(33-35(27)25-10-11-25)21-13-15-34(16-14-21)28(37)18-36/h1-9,12,17,21,25,29,36H,10-11,13-16,18H2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM115403
PNG
(US9682940, 95)
Show SMILES NC(=O)c1ccc(cc1)S(=O)(=O)N1CCC(CC1)c1nn(C2CC2)c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C35H32Cl2N4O3S/c36-27-8-1-22(2-9-27)33(23-3-10-28(37)11-4-23)26-7-16-32-31(21-26)34(39-41(32)29-12-13-29)24-17-19-40(20-18-24)45(43,44)30-14-5-25(6-15-30)35(38)42/h1-11,14-16,21,24,29,33H,12-13,17-20H2,(H2,38,42)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 63n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM115780
PNG
(US9682940, 99)
Show SMILES OC(=O)c1ccc(cc1)C(=O)N1CCC(CC1)c1nn(C2CC2)c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C36H31Cl2N3O3/c37-28-10-5-22(6-11-28)33(23-7-12-29(38)13-8-23)27-9-16-32-31(21-27)34(39-41(32)30-14-15-30)24-17-19-40(20-18-24)35(42)25-1-3-26(4-2-25)36(43)44/h1-13,16,21,24,30,33H,14-15,17-20H2,(H,43,44)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 345n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM115781
PNG
(US9682940, 100)
Show SMILES COc1ccccc1S(=O)(=O)N1CCC(CC1)Nc1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C32H30Cl2N4O3S/c1-41-29-4-2-3-5-30(29)42(39,40)38-18-16-26(17-19-38)35-32-27-20-23(10-15-28(27)36-37-32)31(21-6-11-24(33)12-7-21)22-8-13-25(34)14-9-22/h2-15,20,26,31H,16-19H2,1H3,(H2,35,36,37)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM115783
PNG
(US9682940, 102)
Show SMILES OC(=O)CC(=O)N1CCC(CC1)c1nn(C2CC2)c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C31H29Cl2N3O3/c32-23-6-1-19(2-7-23)30(20-3-8-24(33)9-4-20)22-5-12-27-26(17-22)31(34-36(27)25-10-11-25)21-13-15-35(16-14-21)28(37)18-29(38)39/h1-9,12,17,21,25,30H,10-11,13-16,18H2,(H,38,39)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM115786
PNG
(US9682940, 105 | US9682940, 275)
Show SMILES FC(F)(F)S(=O)(=O)N1CCC(CC1)c1nn(C2CC2)c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C29H26Cl2F3N3O2S/c30-22-6-1-18(2-7-22)27(19-3-8-23(31)9-4-19)21-5-12-26-25(17-21)28(35-37(26)24-10-11-24)20-13-15-36(16-14-20)40(38,39)29(32,33)34/h1-9,12,17,20,24,27H,10-11,13-16H2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 8n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM115787
PNG
(US9682940, 106 | US9682940, 109)
Show SMILES OC(=O)CCS(=O)(=O)N1CCC(CC1)c1nn(C2CC2)c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C31H31Cl2N3O4S/c32-24-6-1-20(2-7-24)30(21-3-8-25(33)9-4-21)23-5-12-28-27(19-23)31(34-36(28)26-10-11-26)22-13-16-35(17-14-22)41(39,40)18-15-29(37)38/h1-9,12,19,22,26,30H,10-11,13-18H2,(H,37,38)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM118563
PNG
(US9682940, 114)
Show SMILES NC(=O)c1ccc(cc1)C(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1
Show InChI InChI=1S/C36H32Cl2N4O2/c37-28-10-5-22(6-11-28)33(23-7-12-29(38)13-8-23)27-9-16-32-31(21-27)34(42(40-32)30-14-15-30)24-17-19-41(20-18-24)36(44)26-3-1-25(2-4-26)35(39)43/h1-13,16,21,24,30,33H,14-15,17-20H2,(H2,39,43)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 283n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM115791
PNG
(US9682940, 115)
Show SMILES NC(=O)CS(=O)(=O)N1CCC(CC1)c1nn(C2CC2)c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C30H30Cl2N4O3S/c31-23-6-1-19(2-7-23)29(20-3-8-24(32)9-4-20)22-5-12-27-26(17-22)30(34-36(27)25-10-11-25)21-13-15-35(16-14-21)40(38,39)18-28(33)37/h1-9,12,17,21,25,29H,10-11,13-16,18H2,(H2,33,37)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM115793
PNG
(US9682940, 120)
Show SMILES NC(=O)c1ccc(cc1)S(=O)(=O)N1CCC(CC1)Nc1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C32H29Cl2N5O3S/c33-24-8-1-20(2-9-24)30(21-3-10-25(34)11-4-21)23-7-14-29-28(19-23)32(38-37-29)36-26-15-17-39(18-16-26)43(41,42)27-12-5-22(6-13-27)31(35)40/h1-14,19,26,30H,15-18H2,(H2,35,40)(H2,36,37,38)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM115794
PNG
(US9682940, 121)
Show SMILES NC(=O)c1ccccc1S(=O)(=O)N1CCC(CC1)Nc1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C32H29Cl2N5O3S/c33-23-10-5-20(6-11-23)30(21-7-12-24(34)13-8-21)22-9-14-28-27(19-22)32(38-37-28)36-25-15-17-39(18-16-25)43(41,42)29-4-2-1-3-26(29)31(35)40/h1-14,19,25,30H,15-18H2,(H2,35,40)(H2,36,37,38)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 375n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM115795
PNG
(US9682940, 122)
Show SMILES NC(=O)c1cccc(c1)S(=O)(=O)N1CCC(CC1)Nc1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C32H29Cl2N5O3S/c33-24-9-4-20(5-10-24)30(21-6-11-25(34)12-7-21)22-8-13-29-28(19-22)32(38-37-29)36-26-14-16-39(17-15-26)43(41,42)27-3-1-2-23(18-27)31(35)40/h1-13,18-19,26,30H,14-17H2,(H2,35,40)(H2,36,37,38)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM118597
PNG
(US9682940, 123)
Show SMILES OC(=O)c1ccccc1S(=O)(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1
Show InChI InChI=1S/C35H31Cl2N3O4S/c36-26-10-5-22(6-11-26)33(23-7-12-27(37)13-8-23)25-9-16-31-30(21-25)34(40(38-31)28-14-15-28)24-17-19-39(20-18-24)45(43,44)32-4-2-1-3-29(32)35(41)42/h1-13,16,21,24,28,33H,14-15,17-20H2,(H,41,42)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 5.80E+3n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM115796
PNG
(US9682940, 125)
Show SMILES CS(=O)(=O)N1CCC(CC1)Nc1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C26H26Cl2N4O2S/c1-35(33,34)32-14-12-22(13-15-32)29-26-23-16-19(6-11-24(23)30-31-26)25(17-2-7-20(27)8-3-17)18-4-9-21(28)10-5-18/h2-11,16,22,25H,12-15H2,1H3,(H2,29,30,31)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 135n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM118707
PNG
(US9682940, 133)
Show SMILES OC(=O)CCS(=O)(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1
Show InChI InChI=1S/C31H31Cl2N3O4S/c32-24-6-1-20(2-7-24)30(21-3-8-25(33)9-4-21)23-5-12-28-27(19-23)31(36(34-28)26-10-11-26)22-13-16-35(17-14-22)41(39,40)18-15-29(37)38/h1-9,12,19,22,26,30H,10-11,13-18H2,(H,37,38)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 3.91E+3n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM118697
PNG
(US9682940, 127 | US9682940, 135)
Show SMILES OC(=O)CCC(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1
Show InChI InChI=1S/C32H31Cl2N3O3/c33-24-6-1-20(2-7-24)31(21-3-8-25(34)9-4-21)23-5-12-28-27(19-23)32(37(35-28)26-10-11-26)22-15-17-36(18-16-22)29(38)13-14-30(39)40/h1-9,12,19,22,26,31H,10-11,13-18H2,(H,39,40)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM118712
PNG
(US9682940, 136)
Show SMILES FC(F)(F)S(=O)(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1
Show InChI InChI=1S/C29H26Cl2F3N3O2S/c30-22-6-1-18(2-7-22)27(19-3-8-23(31)9-4-19)21-5-12-26-25(17-21)28(37(35-26)24-10-11-24)20-13-15-36(16-14-20)40(38,39)29(32,33)34/h1-9,12,17,20,24,27H,10-11,13-16H2
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 11n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM118712
PNG
(US9682940, 136)
Show SMILES FC(F)(F)S(=O)(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1
Show InChI InChI=1S/C29H26Cl2F3N3O2S/c30-22-6-1-18(2-7-22)27(19-3-8-23(31)9-4-19)21-5-12-26-25(17-21)28(37(35-26)24-10-11-24)20-13-15-36(16-14-20)40(38,39)29(32,33)34/h1-9,12,17,20,24,27H,10-11,13-16H2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM118759
PNG
(US9682940, 150 | US9682940, 151)
Show SMILES Oc1cccc(c1)S(=O)(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1
Show InChI InChI=1S/C34H31Cl2N3O3S/c35-26-9-4-22(5-10-26)33(23-6-11-27(36)12-7-23)25-8-15-32-31(20-25)34(39(37-32)28-13-14-28)24-16-18-38(19-17-24)43(41,42)30-3-1-2-29(40)21-30/h1-12,15,20-21,24,28,33,40H,13-14,16-19H2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM118759
PNG
(US9682940, 150 | US9682940, 151)
Show SMILES Oc1cccc(c1)S(=O)(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1
Show InChI InChI=1S/C34H31Cl2N3O3S/c35-26-9-4-22(5-10-26)33(23-6-11-27(36)12-7-23)25-8-15-32-31(20-25)34(39(37-32)28-13-14-28)24-16-18-38(19-17-24)43(41,42)30-3-1-2-29(40)21-30/h1-12,15,20-21,24,28,33,40H,13-14,16-19H2
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM118866
PNG
(US9682940, 154)
Show SMILES CNC(=O)c1ccc(cc1Cl)S(=O)(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1
Show InChI InChI=1S/C36H33Cl3N4O3S/c1-40-36(44)30-14-13-29(21-32(30)39)47(45,46)42-18-16-24(17-19-42)35-31-20-25(6-15-33(31)41-43(35)28-11-12-28)34(22-2-7-26(37)8-3-22)23-4-9-27(38)10-5-23/h2-10,13-15,20-21,24,28,34H,11-12,16-19H2,1H3,(H,40,44)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/an/an/a 4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM118867
PNG
(US9682940, 155)
Show SMILES CNC(=O)c1ccc(cn1)S(=O)(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1
Show InChI InChI=1S/C35H33Cl2N5O3S/c1-38-35(43)32-15-13-29(21-39-32)46(44,45)41-18-16-24(17-19-41)34-30-20-25(6-14-31(30)40-42(34)28-11-12-28)33(22-2-7-26(36)8-3-22)23-4-9-27(37)10-5-23/h2-10,13-15,20-21,24,28,33H,11-12,16-19H2,1H3,(H,38,43)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM118894
PNG
(US9682940, 161)
Show SMILES OC(=O)c1ccc(cc1Cl)S(=O)(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1
Show InChI InChI=1S/C35H30Cl3N3O4S/c36-25-6-1-21(2-7-25)33(22-3-8-26(37)9-4-22)24-5-14-32-30(19-24)34(41(39-32)27-10-11-27)23-15-17-40(18-16-23)46(44,45)28-12-13-29(35(42)43)31(38)20-28/h1-9,12-14,19-20,23,27,33H,10-11,15-18H2,(H,42,43)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM118895
PNG
(US9682940, 162)
Show SMILES OC(=O)c1cc(ccc1F)S(=O)(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1
Show InChI InChI=1S/C35H30Cl2FN3O4S/c36-25-6-1-21(2-7-25)33(22-3-8-26(37)9-4-22)24-5-14-32-30(19-24)34(41(39-32)27-10-11-27)23-15-17-40(18-16-23)46(44,45)28-12-13-31(38)29(20-28)35(42)43/h1-9,12-14,19-20,23,27,33H,10-11,15-18H2,(H,42,43)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM118911
PNG
(US9682940, 166 | US9682940, 167 | US9682940, 200)
Show SMILES OC(=O)c1ccc(cc1F)S(=O)(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1
Show InChI InChI=1S/C35H30Cl2FN3O4S/c36-25-6-1-21(2-7-25)33(22-3-8-26(37)9-4-22)24-5-14-32-30(19-24)34(41(39-32)27-10-11-27)23-15-17-40(18-16-23)46(44,45)28-12-13-29(35(42)43)31(38)20-28/h1-9,12-14,19-20,23,27,33H,10-11,15-18H2,(H,42,43)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 2n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM118913
PNG
(US9682940, 168)
Show SMILES OC(=O)c1cc(ccc1Cl)S(=O)(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1
Show InChI InChI=1S/C35H30Cl3N3O4S/c36-25-6-1-21(2-7-25)33(22-3-8-26(37)9-4-22)24-5-14-32-30(19-24)34(41(39-32)27-10-11-27)23-15-17-40(18-16-23)46(44,45)28-12-13-31(38)29(20-28)35(42)43/h1-9,12-14,19-20,23,27,33H,10-11,15-18H2,(H,42,43)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 2n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM118914
PNG
(US9682940, 169)
Show SMILES NC(=O)c1cc(ccc1Cl)S(=O)(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1
Show InChI InChI=1S/C35H31Cl3N4O3S/c36-25-6-1-21(2-7-25)33(22-3-8-26(37)9-4-22)24-5-14-32-30(19-24)34(42(40-32)27-10-11-27)23-15-17-41(18-16-23)46(44,45)28-12-13-31(38)29(20-28)35(39)43/h1-9,12-14,19-20,23,27,33H,10-11,15-18H2,(H2,39,43)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 17n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))		BDBM118924
PNG
(US9682940, 172)
Show SMILES NC(=O)c1ccoc1S(=O)(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1
Show InChI InChI=1S/C33H30Cl2N4O4S/c34-24-6-1-20(2-7-24)30(21-3-8-25(35)9-4-21)23-5-12-29-28(19-23)31(39(37-29)26-10-11-26)22-13-16-38(17-14-22)44(41,42)33-27(32(36)40)15-18-43-33/h1-9,12,15,18-19,22,26,30H,10-11,13-14,16-17H2,(H2,36,40)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 3n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM118924
PNG
(US9682940, 172)
Show SMILES NC(=O)c1ccoc1S(=O)(=O)N1CCC(CC1)c1n(nc2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1)C1CC1
Show InChI InChI=1S/C33H30Cl2N4O4S/c34-24-6-1-20(2-7-24)30(21-3-8-25(35)9-4-21)23-5-12-29-28(19-23)31(39(37-29)26-10-11-26)22-13-16-38(17-14-22)44(41,42)33-27(32(36)40)15-18-43-33/h1-9,12,15,18-19,22,26,30H,10-11,13-14,16-17H2,(H2,36,40)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 2


(Homo sapiens (Human))		BDBM111145
PNG
(US9682940, 173 | US9682940, 35)
Show SMILES FC(F)(F)S(=O)(=O)N1CCC(CC1)c1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C26H22Cl2F3N3O2S/c27-20-6-1-16(2-7-20)24(17-3-8-21(28)9-4-17)19-5-10-23-22(15-19)25(33-32-23)18-11-13-34(14-12-18)37(35,36)26(29,30)31/h1-10,15,18,24H,11-14H2,(H,32,33)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 5.78E+3n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...

US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 502 total )  |  Next  |  Last  >>
* indicates data uncertainty>20%